NT-I7, a Long-Acting Interleukin 7, Increases Lymphocyte Counts and Induces CD8+ T-cell Clonotype Expansion in Patients with Newly Diagnosed High-Grade Gliomas.

Saved in:
Bibliographic Details
Title: NT-I7, a Long-Acting Interleukin 7, Increases Lymphocyte Counts and Induces CD8+ T-cell Clonotype Expansion in Patients with Newly Diagnosed High-Grade Gliomas.
Authors: Butt OH; Division of Oncology, Department of Medicine, Washington University, St. Louis, Missouri., Singhal K; Division of Oncology, Department of Medicine, Washington University, St. Louis, Missouri., Luo J; Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.; Siteman Cancer Center Biostatistics and Qualitative Research Shared Resource, Washington University School of Medicine, St. Louis, Missouri., Rettig MP; Division of Oncology, Department of Medicine, Washington University, St. Louis, Missouri., Foltz JA; Division of Oncology, Department of Medicine, Washington University, St. Louis, Missouri., Huang J; Department of Radiation Oncology, Washington University, St. Louis, Missouri., Zhou AY; Division of Oncology, Department of Medicine, Washington University, St. Louis, Missouri., Tao Y; Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.; Siteman Cancer Center Biostatistics and Qualitative Research Shared Resource, Washington University School of Medicine, St. Louis, Missouri., Griffith OL; Division of Oncology, Department of Medicine, Washington University, St. Louis, Missouri., Griffith M; Division of Oncology, Department of Medicine, Washington University, St. Louis, Missouri., Johanns TM; Division of Oncology, Department of Medicine, Washington University, St. Louis, Missouri., Ansstas G; Division of Oncology, Department of Medicine, Washington University, St. Louis, Missouri., Zhang C; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Tang J; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Christ S; Division of Oncology, Department of Medicine, Washington University, St. Louis, Missouri., Ferrando-Martinez S; NeoImmuneTech, Inc., Rockville, Maryland., Lee BH; NeoImmuneTech, Inc., Rockville, Maryland., DiPersio JF; Division of Oncology, Department of Medicine, Washington University, St. Louis, Missouri., Chheda MG; Division of Oncology, Department of Medicine, Washington University, St. Louis, Missouri., Fehniger TA; Division of Oncology, Department of Medicine, Washington University, St. Louis, Missouri., Campian JL; Department of Oncology, Mayo Clinic, Rochester, Minnesota.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 Jul 01; Vol. 32 (13), pp. 2581-2592.
Publication Type: Journal Article; Clinical Trial, Phase I
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-25-2953